New Blood Pressure Guidelines Raise the Bar for Taking Medications; Expert Panel Says Treating Some Earlier with Drugs Shows Little Benefit, but Other Groups Express ConcernThompson, Dennis
High blood pressure is very widespread in Germany – 20 to 30 million people in Germany are affected. However, around one in ten people do not seek treatment even though they know they have high blood pressure. This can be dangerous: If blood pressure remains untreated, it can damage...
Medications for diabetes comprise either GLP-1 receptor agonists, with short (one or two daily injections: Exenatide, Liraglutide, Lixisenatide) or long duration (one injection once weekly: extended-released Exenatide, Albiglutide, Dulaglutide, Taspoglutide); or oral compounds inhibiting dipeptidyl peptid...
For a complete list of migraine treatments, see Medications for MigraineRead nextWhy does Imitrex (sumatriptan) make me feel weird? Imitrex (sumatriptan) can cause a variety of side effects, which may make you feel weird after taking it. It is not fully understood what causes these side ...
More than 7 years of hindsight: revisiting the FDA’s 2008 guidance on cardiovascular outcomes trials for type 2 diabetes medications. Clin Diabetes. 2016;34(4):173–80. Article PubMed PubMed Central Google Scholar U.S. Food and Drug Administration. Guidance for industry diabetes mellitus—...
Most anti-inflammatory medications are linked to an elevated risk of severe upper gastrointestinal problems. The level of risk for particular anti-inflammatory drugs has been estimated through epidemiological studies. Through the use of oral steroids or low-dose aspirin, the likelihood of upper gastroin...
Medications for diabetes comprise either GLP-1 receptor agonists, with short (one or two daily injections: Exenatide, Liraglutide, Lixisenatide) or long duration (one injection once weekly: extended-released Exenatide, Albiglutide, Dulaglutide, Taspoglutide); or oral compounds inhibiting dipeptidyl peptid...
The 9th Cardiovascular Outcome Trial (CVOT) Summit: Congress on Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on November 30-December 1, 2023. This reference congress served as a platform for in-depth discussions and exchange on recen
The Symplicity™ blood pressure procedure (BPP) is a minimally invasive procedure approved to help lower high blood pressure. The procedure is approved as a complement to treatments you may already be trying, such as lifestyle modifications and high blood pressure medications that ...
If I have 3 medications fail, they may offer me surgery, which I will most definitely decline. I don’t want a lobotomy. And even though I gave up drinking more than 20 years ago, I would still rather have a bottle in front of me, than a frontal lobotomy. Boom tish. Seriously, ...